Featured news
-
Clinician webinar: Circulating Tumour DNA project
In support of the national roll-out of ctDNA testing to a further 10,000 patients, we are running two identical 30 minute sessions on Monday 29 April, and Thursday 2 May 2024, to share with healthcare staff the pathway, supporting resources/documentation and information on the testing process including how to order testing kits.
-
Blood test reveals best lung cancer treatment
Thousands of patients in England with suspected lung cancer are being offered a blood test which can show if they can get early access to targeted therapies.
-
Next generation genomic testing brings benefits to patients and clinicians at NUH
Genomic testing is an important tool in the diagnosis of many rare conditions and cancers. But when it comes to cancer, it can also help to understand a patient’s prognosis, for example how quickly their cancer is likely to grow. However, perhaps most importantly for most cancer patients, gene variants revealed through genomic testing can also help doctors provide more effective treatments, with potentially fewer side-effects, via targeted therapies.
-
Genomics BITE: Pharmacogenomic testing prior to aminoglycoside use
Our series of regular Genomics BITE sessions provide healthcare staff with updates, information and training on key areas of genomic medicine and testing.
-
Lynch Syndrome Awareness Day: 22 March 2024
Lynch Syndrome Awareness Day in 2024 is Friday 22 March. You can read some clinician and patient stories on this page which shed light on this common genetic condition.
-
Introducing our new Cancer Lead for the East Midlands
We're delighted to welcome Professor Srinivasan Madhusudan who joins us as Cancer Lead for the East Midlands.
All news
Clinician webinar: Circulating Tumour DNA project
In support of the national roll-out of ctDNA testing to a further 10,000 patients, we are running two identical 30 minute sessions on Monday 29 April, and Thursday 2 May 2024, to share with healthcare staff the pathway, supporting resources/documentation and information on the testing process including how to order testing kits.
Blood test reveals best lung cancer treatment
Thousands of patients in England with suspected lung cancer are being offered a blood test which can show if they can get early access to targeted therapies.
Next generation genomic testing brings benefits to patients and clinicians at NUH
Genomic testing is an important tool in the diagnosis of many rare conditions and cancers. But when it comes to cancer, it can also help to understand a patient’s prognosis, for example how quickly their cancer is likely to grow. However, perhaps most importantly for most cancer patients, gene variants revealed through genomic testing can also help doctors provide more effective treatments, with potentially fewer side-effects, via targeted therapies.
Genomics BITE: Pharmacogenomic testing prior to aminoglycoside use
Our series of regular Genomics BITE sessions provide healthcare staff with updates, information and training on key areas of genomic medicine and testing.
Lynch Syndrome Awareness Day: 22 March 2024
Lynch Syndrome Awareness Day in 2024 is Friday 22 March. You can read some clinician and patient stories on this page which shed light on this common genetic condition.
Introducing our new Cancer Lead for the East Midlands
We're delighted to welcome Professor Srinivasan Madhusudan who joins us as Cancer Lead for the East Midlands.
Upcoming Genomics Forums: Prenatal Medicine
Here at East Genomics we now run two regular Genomics Forums aimed at specific groups of clinicians - those working in Paediatrics and those working in Prenatal Medicine.
Genomics BITE: R445 Testing Pathway
Our first Genomics BITE session of 2024 focusses on the R445 testing pathway, which is a new addition to the National Testing Directory expected to be implemented into maternity services by 1 April 2024.
Are midwives ready for the Genomics Era?
Taken from the Maternity and Midwifery Forum website, this article by our Lead Midwife, Joanne Hargrave, highlights developments around genomics and how midwives and students need to keep up-to-date in order to provide appropriate information and care.
Lynch Syndrome patient event in April
Do you have a diagnosis of Lynch Syndrome? Join us for a FREE patient event in Nottingham (with virtual joining option) on 22 April 2024.
Rare Disease Day 2024
This year Rare Disease Day - an annual international day to raise awareness of rare diseases and conditions - is itself even more rare as it falls on 29 February this leap year!
Gene-editing offers hope for people with hereditary disorder
A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, a study reports.
East Genomics at Festival of Genomics and Biodata
We hear from Jo and Chris, both based at Norfolk and Norwich University Hospitals NHS Foundation Trust, who spoke at the Festival of Genomics and Biodata held in London, 24-45 January 2024.
NEW East region Prenatal Genomics Forum
We are pleased to invite anyone working in Feto-Maternal or Prenatal services, midwifery or genetics to join our new Prenatal Genomics Forum for the East region.
Our January 2024 newsletter out now!
Our latest East Genomics newsletter is out.
Thousands of people with inherited blood disorders to get world-first NHS test to curb transfusion side effects
From today, almost 18,000 people in England with sickle cell disorder and thalassaemia can have a world-first genetic test to better match future blood transfusions, reducing the risk of side effects.
Recruitment: Opportunity for TWO GP Leads
We have an exciting opportunity for two GPs to support transformation of the health and care of patients and communities through a fast-changing national Genomic Medicine Service that will provide equitable and consistent access to services across the East GMSA geography.
NHS Genomic Networks of Excellence
NHSE has announced funding for eight new NHS Genomic Networks of Excellence.
Genomics Education Programme Patient Experience Survey
The Genomics Education Programme (GEP) has launched a new patient survey and are encouraging patients from across the UK with experience of genomic testing to take part.
Landmark national study supports use of whole genome sequencing in standard cancer care
In the largest study of its kind, scientists today report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their patients.